The have enough cash to last them for the next 1.5 years, no exposure to dilution and have 6 drugs in the pipeline.

$HTGM $THER Ther good buy with 1$ soon Theralink.com Tests available for cancers and rppa tech for treatments Ther stock symbol

$DRUG Low Risk High Reward Type play Could be very lucrative Swing idea down here $vs $htgm

$SONM I sent the alert 🚨 It’s about to 💣🆙 Get it now $HTGM congrats 🎊🎈🎉 $REBN looks like it can gap down now $FFIE nice move today 👍🏻 $APVO makes nice drugs .

$BIRD Will fly 🦅 high next week Load it Monday $REBN I called this out 12/7 Another winner 🏆💲 $AMAM 🎅 came early 🤩 $HTGM makes good drugs and 💲 $BXRX Pharma is 🔥

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.

“Unlike single- or multi-dose vials that may require drug product overfill by as much as 30% to ensure adequate withdrawal, a prefilled syringe can virtually eliminate the need for excess overfill, thus conserving expensive drug products.

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.

Lots of positive chatter amongst physicians and patients who are holding Tyvaso DPI in high regard and as a life changing medical treatment.

Explanation, Technosphere is a known and safe incipient as defined by the FDA and its use as such in drug delivery is now a known and accepted incipient!

The opportunity is huge to get a lot more Technosphere drugs in the pipeline targeting many diseases & disorders, that could do as good, if not better than Tyvaso DPI.

Tyvaso DPI has clearly demonstrated it to a superior way to deliver drugs in to lung using less dose that delivers high concentration of the medication and it delivers it deeper in the lung.

Either way congrats to the CEO for now finding a great purchase in VGo and now a potential drug in his acquisition of Clofazamine from Qrumpharma.

Allow strong sales for Tyvaso DPI to deliver growing royalties & manufacturing fees, CIPLA PHASE III read-out & positive drug pipeline news to drive increasing market cap/stock price throughout 2023.

"Transforming Evidence Generation for Drug Label Changes: A Case Study" Precursor to Afrezza label change - very promising!! !

$MNKD Sildenafil is a very interesting drug.

Increasing revenues quarter over quarter with profitability here in 2023 combined with a solid partner who depends on us for their blockbuster drug allows me to chill and sleep peacefully at night.

The good part is that Ralinapag is a great additive drug and will not cross compete with Tyvaso DPI.